Developer docs
API playgroundTry for free, no card

Search company profiles

Phenomics Australia

Full company profile

uuid0031kws

Namestring
Phenomics Australia
Legal namestring
Phenomics Australia
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Phenomics Australia is a non-profit national research infrastructure organisation headquartered in Canberra that delivers openly accessible phenomics and genomics services to Australian researchers and clinicians. Established in 2007 (originally as the Australian Phenomics Network) and a founding member of the National Collaborative Research Infrastructure Strategy (NCRIS), it operates a distributed network of more than 20 service delivery centres across Australia, staffed by 200+ technical experts and embedded in 15+ host institutions including the Australian National University, Peter MacCallum Cancer Centre, WEHI, Monash University, University of Queensland, MCRI, and Victor Chang Cardiac Research Institute.

Its core service portfolio spans six integrated capabilities: biobanking of mouse sperm and embryos; in vivo and in vitro genome engineering and disease modelling (including the world's first RASTRUM 3D bioprinter installation at Peter Mac's Victorian Centre for Functional Genomics, CRISPR gene editing, organoids, and organ-on-chip systems); genotyping and phenotyping with next-generation sequencing and bioinformatics; functional genomics and high-throughput screening (CRISPR, RNAi, and compound screens with automated liquid handling); and pathology services. Underlying technology combines capital-intensive instrumentation (RASTRUM 3D bioprinter, automated screening platforms, cryobanks, sequencing infrastructure) with proprietary protocols, three granted international patents held by affiliated PIs (e.g., Prof Alice Pebay), and global technology partnerships including Inventia Life Science, The Jackson Laboratory, St Jude Children's Research Hospital, and Fudan University.

The business model is government-funded research infrastructure rather than commercial product sales. Core operations are subsidised by NCRIS (with the non-animal modelling programme budget expanded to $12.2M through 2028), and the organisation has secured competitive project grants from MRFF ($2.975M stem cell governance in 2026; $2.8M for the Canberra Clinical Phenomics Service in 2024), NHMRC ($1.36M Ideas Grant in 2022), and the ACT Government ($525K). Pricing is project- and voucher-based, services are openly accessible to researchers, and there is no disclosed commercial revenue. Customer segments are predominantly Australian academic and clinical researchers served via the national node network, supplemented by industry collaborators and international research partnerships; outreach occurs through the website, LinkedIn, Bluesky, conference participation (ACRI, CORES, ASSCR, ISBER), workshops, and the PHENOMENA news platform.

Short descriptiontext

Phenomics Australia is a Canberra-based, non-profit national research infrastructure provider operating 20+ service centres across Australia. It delivers subsidised biobanking, genome engineering, disease modelling, and high-throughput screening services to academic and clinical researchers, funded primarily through NCRIS government grants.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCanberra, Australia
HQ citystring
Canberra
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
phenomics research services, genome engineering services, disease modelling infrastructure, biobanking cryopreservation, high-throughput screening
Industry2 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Biomedical Research Infrastructure Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Research Infrastructure Services
TypeSubscription Recurring
Description

Subsidized research infrastructure services funded through the National Collaborative Research Infrastructure Strategy (NCRIS). Services are openly accessible to researchers across Australia with government support to make research infrastructure affordable and accessible.

phenomicsaustralia.org.au
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Subsidized research infrastructure access
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Services are subsidized by NCRIS funding; specific pricing varies by service type and project requirements

phenomicsaustralia.org.au
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Phenomics Australia is a non-profit national research infrastructure provider offering specialized phenomics services across Australia through a network of 20+ service delivery centres. Its core offerings include biobanking of mouse sperm and embryos, in vivo and in vitro genome engineering and disease modelling, genotyping and phenotyping with integrated bioinformatics, functional genomics and high-throughput screening, and pathology services. These services are subsidized by Australian Government NCRIS funding and made openly accessible to academic, clinical, and industry researchers to advance precision medicine.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Delivered well over 1000 projects for over 300 researchers through non-animal modelling services
+2 more records
Product overview1 text field

Phenomics Australia is a national research infrastructure consortium providing specialized phenomics and genomics services across Australia through 20+ locations. The core offerings include six major service areas: Biobanking (mouse sperm/embryo cryobank), In Vivo Genome Engineering & Disease Modelling, In Vitro Genome Engineering & Disease Modelling (cell/organoid/tissue-based models, 3D bioprinting), Genotyping & Phenotyping, Functional Genomics & High-Throughput Screening (CRISPR/RNAi/compound screening), and Pathology. Key specialized services include the RASTRUM 3D Bioprinter (world's first installation at VCFG, Peter Mac), CRISPR in Cells Service, and a Non-Animal Models consortium offering iPS cells, organoids, and organ-on-chip systems. Services are delivered through a distributed network of nodes at institutions including ANU, Peter MacCallum Cancer Centre, WEHI, Monash University, UQ, MCRI, and others.

Product and service10 records
1Biobanking
CategoryBiobanking Services
Description

Database and cryobank of mouse sperm and embryos essential for discovering and distributing disease models in Australia, available to academic, clinical, and industry researchers.

2In Vivo Genome Engineering & Disease Modelling
CategoryDisease Modelling Services
Description

National capability producing bespoke in vivo models with targeted mutations of interest that replicate clinical findings, used by researchers to study the genetic basis of health and disease, particularly rare diseases.

3In Vitro Genome Engineering & Disease Modelling
CategoryDisease Modelling Services
Description

Cell-, organoid-, and tissue-based in vitro models including 3D bioprinting for studying disease mechanisms and developing new therapies, complementing in vivo capabilities.

4Genotyping & Phenotyping
CategoryGenomic Analysis Services
Description

Next-generation screening and sequencing technology with integrated bioinformatics capabilities enabling researchers to identify new genomic variants and understand how they contribute to disease.

5Functional Genomics & High-Throughput Screening
CategoryScreening Services
Description

Genome-scale cell-based CRISPR, RNAi, and compound screening in 2D and 3D cell lines, PDX, patient-derived cells, and complex disease models using sophisticated liquid handling automation, high-content cellular phenotyping, and reporter-based readouts.

6Pathology Services
CategoryPathology Services
Description

Detailed pathological analysis of disease models to determine biological consequences of genome modifications, relate mutant phenotypes to human disease, and support drug development through identification of off-target effects.

7CRISPR Gene Editing in Cells Service
CategoryGenome Engineering Services
Description

Genome modification service in cell lines using CRISPR/Cas9 gene editing to produce bespoke cellular models of disease by generating targeted mutations that replicate clinical findings.

8RASTRUM 3D Bioprinter Access
Category3D Bioprinting Services
Description

Access to the world's first deployed RASTRUM 3D bioprinter for cellular applications, embedding cells and 3D cellular structures in a customised hydrogel suitable for high-throughput screening, located at VCFG at Peter Mac.

9Non-Animal Models Services
CategoryDisease Modelling Services
Description

National consortium providing non-animal disease modelling technologies including CRISPR engineered cell lines, iPS cells, tissue cultures, organoids, 3D bioprinting, and organ-on-chip systems, delivered through a network of service nodes.

10Voucher Scheme
CategoryAccess Program
Description

Funded access program providing subsidised vouchers for researchers to use Phenomics Australia's infrastructure and expertise across its service portfolio.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
1Academy for Collaborative Research Infrastructure (ACRI)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-01
Description

Phenomics Australia is a Foundation Contributor in ACRI's establishment. ACRI is dedicated to education, training, and professional development of the workforce employed by national research infrastructure facilities.

phenomicsaustralia.org.au
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Co-developed the RASTRUM 3D bioprinter with Phenomics Australia technical staff refining workflows, validating applications, and supporting early adoption. The technology won a Eureka Prize in 2021 and is now sold in 26 countries.

3Peter MacCallum Cancer Centre
Strategic tierCoreTypeTechnology or Integration
Description

Home to the Victorian Centre for Functional Genomics (VCFG), a Phenomics Australia node that hosts the RASTRUM 3D bioprinter and provides high-throughput screening services.

phenomicsaustralia.org.au
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on stem cell governance project to establish sustainable systems for ethical, collaborative and impactful stem cell research across Australia.

5SMART CRC
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Phenomics Australia is a partner in the $238M SMART CRC initiative to transform Australia's regenerative-therapy manufacturing landscape, bringing together 63 partners.

phenomicsaustralia.org.au
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for the Human Immune Model Facility (HIMF) generating high-quality preclinical models with humanised immune systems.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Professor Kristen Radford instrumental in developing humanized immune system models at the Translational Research Institute for HIMF.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in HIMF initiative for humanized immune model development.

9Queensland Cord Blood Bank
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in HIMF initiative for humanized immune model development.

phenomicsaustralia.org.au
10Bioplatforms Australia
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Supporting the Australian Psychiatric Research Knowledge Bank initiative to advance mental disorder research through large-scale omics data generation.

phenomicsaustralia.org.au
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International partnership established in 2014 with Peter Doherty Institute for infectious disease research, including OLAH gene discovery collaboration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global collaboration on respiratory viral infection research including OLAH gene severity studies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Home to multiple Phenomics Australia nodes including Australian Phenomics Facility, ANU Centre for Therapeutic Discovery, and new Canberra Clinical Phenomics Service.

14Consortium for Preclinical Psychiatric Research (CPPR)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Led by Professor Suresh Sundram and Associate Professor Rachel Hill from Monash University, developing the Australian Psychiatric Research Knowledge Bank.

phenomicsaustralia.org.au
15Australasian Biospecimen Network Association (ABNA)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on biobanking workshops and national biobanking strategy development.

phenomicsaustralia.org.au
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-sponsoring Australian Functional Genomics Symposium and collaboration within NCRIS Health Group.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on showcasing Australia's national research infrastructure for therapeutic innovation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

WuXi AppTec is one of the largest global CRO/CDMO organizations offering preclinical research services including in vivo and in vitro disease modelling, genomics, and bioanalytical services. A broad incumbent comparable in service breadth to Phenomics Australia, but with vastly greater international scale.

TypeBroad incumbent
Description

Crown Bioscience is a global CRO providing preclinical and translational drug discovery services including oncology and metabolic disease models, with strengths in patient-derived xenografts and in vivo phenotyping. Overlaps with Phenomics Australia's disease modelling and high-throughput screening capabilities.

TypeEmerging player
Description

Newcells Biotech provides organoid and in vitro disease modelling services, including organ-on-chip systems, to pharmaceutical and academic clients. Directly comparable to Phenomics Australia's non-animal modelling and organoid capabilities, but at smaller commercial scale.

TypeOthers
Description

Inotiv is a CRO specializing in preclinical research services, including animal disease models, phenotyping, and pathology services. Overlaps with Phenomics Australia's in vivo modelling and pathology offerings but operates in a commercial, public-company context.

TypeBroad incumbent
Description

JAX is a global non-profit research institute specializing in mouse genetics, disease modelling, and humanised immune models. It is both a direct partner of Phenomics Australia on the HIMF initiative and a leading international comparator in preclinical phenomics and biobanking infrastructure.

TypeDirect peer
Description

Taconic is a global provider of genetically engineered mouse models, colony management, and related preclinical research services. Directly comparable to Phenomics Australia's in vivo genome engineering, biobanking, and disease modelling service lines.

TypeEmerging player
Description

Cyagen provides custom genetically engineered mouse and rat models, cell line engineering, and related preclinical services globally. Comparable to Phenomics Australia's in vivo and in vitro genome engineering and disease modelling service lines.

TypeBroad incumbent
Description

Charles River is a major global CRO providing preclinical research services including disease models, phenotyping, and discovery services. Comparable to Phenomics Australia in the breadth of preclinical capabilities, but operating commercially and at significantly larger scale internationally.

9Bioplatforms Australia
TypeDirect peer
Description

Bioplatforms Australia is a fellow NCRIS-funded national research infrastructure provider offering 'omics services (genomics, metabolomics, proteomics). It is a peer within Australia's NCRIS network, co-supporting initiatives like the Australian Psychiatric Research Knowledge Bank with Phenomics Australia.

TypeDirect peer
Description

Inventia Life Science is the manufacturer and global distributor of the RASTRUM 3D bioprinter, co-developed with Phenomics Australia. As the commercial arm of the technology platform, Inventia is the closest commercial peer and distribution partner for Phenomics Australia's 3D bioprinting-based disease modelling services.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Phenomics Australia

Biomedical Research Infrastructure Servicesphenomicsaustralia.org.au

Phenomics Australia is a Canberra-based, non-profit national research infrastructure provider operating 20+ service centres across Australia. It delivers subsidised biobanking, genome engineering, disease modelling, and high-throughput screening services to academic and clinical researchers, funded primarily through NCRIS government grants.

What Phenomics Australia does

Phenomics Australia is a non-profit national research infrastructure organisation headquartered in Canberra that delivers openly accessible phenomics and genomics services to Australian researchers and clinicians. Established in 2007 (originally as the Australian Phenomics Network) and a founding member of the National Collaborative Research Infrastructure Strategy (NCRIS), it operates a distributed network of more than 20 service delivery centres across Australia, staffed by 200+ technical experts and embedded in 15+ host institutions including the Australian National University, Peter MacCallum Cancer Centre, WEHI, Monash University, University of Queensland, MCRI, and Victor Chang Cardiac Research Institute.

Its core service portfolio spans six integrated capabilities: biobanking of mouse sperm and embryos; in vivo and in vitro genome engineering and disease modelling (including the world's first RASTRUM 3D bioprinter installation at Peter Mac's Victorian Centre for Functional Genomics, CRISPR gene editing, organoids, and organ-on-chip systems); genotyping and phenotyping with next-generation sequencing and bioinformatics; functional genomics and high-throughput screening (CRISPR, RNAi, and compound screens with automated liquid handling); and pathology services. Underlying technology combines capital-intensive instrumentation (RASTRUM 3D bioprinter, automated screening platforms, cryobanks, sequencing infrastructure) with proprietary protocols, three granted international patents held by affiliated PIs (e.g., Prof Alice Pebay), and global technology partnerships including Inventia Life Science, The Jackson Laboratory, St Jude Children's Research Hospital, and Fudan University.

The business model is government-funded research infrastructure rather than commercial product sales. Core operations are subsidised by NCRIS (with the non-animal modelling programme budget expanded to $12.2M through 2028), and the organisation has secured competitive project grants from MRFF ($2.975M stem cell governance in 2026; $2.8M for the Canberra Clinical Phenomics Service in 2024), NHMRC ($1.36M Ideas Grant in 2022), and the ACT Government ($525K). Pricing is project- and voucher-based, services are openly accessible to researchers, and there is no disclosed commercial revenue. Customer segments are predominantly Australian academic and clinical researchers served via the national node network, supplemented by industry collaborators and international research partnerships; outreach occurs through the website, LinkedIn, Bluesky, conference participation (ACRI, CORES, ASSCR, ISBER), workshops, and the PHENOMENA news platform.

Phenomics Australia firmographics

Firmographics
Name
Phenomics Australia
Legal name
Phenomics Australia
Website
https://phenomicsaustralia.org.au
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
Phenomics Australia is a Canberra-based, non-profit national research infrastructure provider operating 20+ service centres across Australia. It delivers subsidised biobanking, genome engineering, disease modelling, and high-throughput screening services to academic and clinical researchers, funded primarily through NCRIS government grants.
Ownership category
akta.pro rank

Phenomics Australia industry classification

Industry
Product category
Biomedical Research Infrastructure Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Phenomics research services
  • Genome engineering services
  • Disease modelling infrastructure
  • Biobanking cryopreservation
  • High-throughput screening

Where Phenomics Australia is headquartered

Location

Headquarters

HQ city
Canberra
HQ country
Australia
HQ region
Oceania

Offices7 records

Markets served

Phenomics Australia business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Research Infrastructure Services: Subsidized research infrastructure services funded through the National Collaborative Research Infrastructure Strategy (NCRIS). Services are openly accessible to researchers across Australia with government support to make research infrastructure affordable and accessible.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractSubsidized research infrastructure access

Go-to-market motion1 record

Distribution channels3 records

Marketing channels10 records

Phenomics Australia product offering

Product offering

Core offering

Phenomics Australia is a non-profit national research infrastructure provider offering specialized phenomics services across Australia through a network of 20+ service delivery centres. Its core offerings include biobanking of mouse sperm and embryos, in vivo and in vitro genome engineering and disease modelling, genotyping and phenotyping with integrated bioinformatics, functional genomics and high-throughput screening, and pathology services. These services are subsidized by Australian Government NCRIS funding and made openly accessible to academic, clinical, and industry researchers to advance precision medicine.

Product overview

Phenomics Australia is a national research infrastructure consortium providing specialized phenomics and genomics services across Australia through 20+ locations. The core offerings include six major service areas: Biobanking (mouse sperm/embryo cryobank), In Vivo Genome Engineering & Disease Modelling, In Vitro Genome Engineering & Disease Modelling (cell/organoid/tissue-based models, 3D bioprinting), Genotyping & Phenotyping, Functional Genomics & High-Throughput Screening (CRISPR/RNAi/compound screening), and Pathology. Key specialized services include the RASTRUM 3D Bioprinter (world's first installation at VCFG, Peter Mac), CRISPR in Cells Service, and a Non-Animal Models consortium offering iPS cells, organoids, and organ-on-chip systems. Services are delivered through a distributed network of nodes at institutions including ANU, Peter MacCallum Cancer Centre, WEHI, Monash University, UQ, MCRI, and others.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biobanking Database and cryobank of mouse sperm and embryos essential for discovering and distributing disease models in Australia, available to academic, clinical, and industry researchers.
  • In Vivo Genome Engineering & Disease Modelling National capability producing bespoke in vivo models with targeted mutations of interest that replicate clinical findings, used by researchers to study the genetic basis of health and disease, particularly rare diseases.
  • In Vitro Genome Engineering & Disease Modelling Cell-, organoid-, and tissue-based in vitro models including 3D bioprinting for studying disease mechanisms and developing new therapies, complementing in vivo capabilities.
  • Genotyping & Phenotyping Next-generation screening and sequencing technology with integrated bioinformatics capabilities enabling researchers to identify new genomic variants and understand how they contribute to disease.
  • Functional Genomics & High-Throughput Screening Genome-scale cell-based CRISPR, RNAi, and compound screening in 2D and 3D cell lines, PDX, patient-derived cells, and complex disease models using sophisticated liquid handling automation, high-content cellular phenotyping, and reporter-based readouts.
  • Pathology Services Detailed pathological analysis of disease models to determine biological consequences of genome modifications, relate mutant phenotypes to human disease, and support drug development through identification of off-target effects.
  • CRISPR Gene Editing in Cells Service Genome modification service in cell lines using CRISPR/Cas9 gene editing to produce bespoke cellular models of disease by generating targeted mutations that replicate clinical findings.
  • RASTRUM 3D Bioprinter Access Access to the world's first deployed RASTRUM 3D bioprinter for cellular applications, embedding cells and 3D cellular structures in a customised hydrogel suitable for high-throughput screening, located at VCFG at Peter Mac.
  • Non-Animal Models Services National consortium providing non-animal disease modelling technologies including CRISPR engineered cell lines, iPS cells, tissue cultures, organoids, 3D bioprinting, and organ-on-chip systems, delivered through a network of service nodes.
  • Voucher Scheme Funded access program providing subsidised vouchers for researchers to use Phenomics Australia's infrastructure and expertise across its service portfolio.

Quantifiable outcome

  • Delivered well over 1000 projects for over 300 researchers through non-animal modelling services
  • +2 more outcomes

Companies that use Phenomics Australia

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Phenomics Australia technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Phenomics Australia partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core and flagship.

  • Academy for Collaborative Research Infrastructure (ACRI)coreStrategic or Co-development Partner · 1 July 2026Phenomics Australia is a Foundation Contributor in ACRI's establishment. ACRI is dedicated to education, training, and professional development of the workforce employed by national research infrastructure facilities.
  • Inventia Life ScienceflagshipStrategic or Co-development PartnerCo-developed the RASTRUM 3D bioprinter with Phenomics Australia technical staff refining workflows, validating applications, and supporting early adoption. The technology won a Eureka Prize in 2021 and is now sold in 26 countries.
  • Peter MacCallum Cancer CentrecoreTechnology or IntegrationHome to the Victorian Centre for Functional Genomics (VCFG), a Phenomics Australia node that hosts the RASTRUM 3D bioprinter and provides high-throughput screening services.
  • Garvan Institute's CTRL PlatformcoreStrategic or Co-development PartnerCollaboration on stem cell governance project to establish sustainable systems for ethical, collaborative and impactful stem cell research across Australia.
  • SMART CRCflagshipStrategic or Co-development PartnerPhenomics Australia is a partner in the $238M SMART CRC initiative to transform Australia's regenerative-therapy manufacturing landscape, bringing together 63 partners.
  • The Jackson Laboratory (JAX)coreStrategic or Co-development PartnerPartnership for the Human Immune Model Facility (HIMF) generating high-quality preclinical models with humanised immune systems.
  • Mater ResearchcoreStrategic or Co-development PartnerProfessor Kristen Radford instrumental in developing humanized immune system models at the Translational Research Institute for HIMF.
  • University of QueenslandcoreStrategic or Co-development PartnerPartner in HIMF initiative for humanized immune model development.
  • Queensland Cord Blood BankcoreStrategic or Co-development PartnerPartner in HIMF initiative for humanized immune model development.
  • Bioplatforms AustraliacoreStrategic or Co-development PartnerSupporting the Australian Psychiatric Research Knowledge Bank initiative to advance mental disorder research through large-scale omics data generation.
  • Fudan UniversitycoreStrategic or Co-development PartnerInternational partnership established in 2014 with Peter Doherty Institute for infectious disease research, including OLAH gene discovery collaboration.
  • St Jude Children's Research HospitalcoreStrategic or Co-development PartnerGlobal collaboration on respiratory viral infection research including OLAH gene severity studies.
  • Australian National UniversitycoreStrategic or Co-development PartnerHome to multiple Phenomics Australia nodes including Australian Phenomics Facility, ANU Centre for Therapeutic Discovery, and new Canberra Clinical Phenomics Service.
  • Consortium for Preclinical Psychiatric Research (CPPR)coreStrategic or Co-development PartnerLed by Professor Suresh Sundram and Associate Professor Rachel Hill from Monash University, developing the Australian Psychiatric Research Knowledge Bank.
  • Australasian Biospecimen Network Association (ABNA)coreStrategic or Co-development PartnerCollaboration on biobanking workshops and national biobanking strategy development.
  • Therapeutic Innovation AustraliacoreStrategic or Co-development PartnerCo-sponsoring Australian Functional Genomics Symposium and collaboration within NCRIS Health Group.
  • MTPConnectcoreStrategic or Co-development PartnerCollaboration on showcasing Australia's national research infrastructure for therapeutic innovation.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Phenomics Australia competitors and assessment

Company assessment

Broad incumbents

  • WuXi AppTec: WuXi AppTec is one of the largest global CRO/CDMO organizations offering preclinical research services including in vivo and in vitro disease modelling, genomics, and bioanalytical services. A broad incumbent comparable in service breadth to Phenomics Australia, but with vastly greater international scale.
  • Crown Bioscience: Crown Bioscience is a global CRO providing preclinical and translational drug discovery services including oncology and metabolic disease models, with strengths in patient-derived xenografts and in vivo phenotyping. Overlaps with Phenomics Australia's disease modelling and high-throughput screening capabilities.
  • The Jackson Laboratory (JAX): JAX is a global non-profit research institute specializing in mouse genetics, disease modelling, and humanised immune models. It is both a direct partner of Phenomics Australia on the HIMF initiative and a leading international comparator in preclinical phenomics and biobanking infrastructure.
  • Charles River Laboratories: Charles River is a major global CRO providing preclinical research services including disease models, phenotyping, and discovery services. Comparable to Phenomics Australia in the breadth of preclinical capabilities, but operating commercially and at significantly larger scale internationally.

Emerging players

  • Newcells Biotech: Newcells Biotech provides organoid and in vitro disease modelling services, including organ-on-chip systems, to pharmaceutical and academic clients. Directly comparable to Phenomics Australia's non-animal modelling and organoid capabilities, but at smaller commercial scale.
  • Cyagen Biosciences: Cyagen provides custom genetically engineered mouse and rat models, cell line engineering, and related preclinical services globally. Comparable to Phenomics Australia's in vivo and in vitro genome engineering and disease modelling service lines.

Others

  • Inotiv: Inotiv is a CRO specializing in preclinical research services, including animal disease models, phenotyping, and pathology services. Overlaps with Phenomics Australia's in vivo modelling and pathology offerings but operates in a commercial, public-company context.

Direct peers

  • Taconic Biosciences: Taconic is a global provider of genetically engineered mouse models, colony management, and related preclinical research services. Directly comparable to Phenomics Australia's in vivo genome engineering, biobanking, and disease modelling service lines.
  • Bioplatforms Australia: Bioplatforms Australia is a fellow NCRIS-funded national research infrastructure provider offering 'omics services (genomics, metabolomics, proteomics). It is a peer within Australia's NCRIS network, co-supporting initiatives like the Australian Psychiatric Research Knowledge Bank with Phenomics Australia.
  • Inventia Life Science: Inventia Life Science is the manufacturer and global distributor of the RASTRUM 3D bioprinter, co-developed with Phenomics Australia. As the commercial arm of the technology platform, Inventia is the closest commercial peer and distribution partner for Phenomics Australia's 3D bioprinting-based disease modelling services.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Phenomics Australia social profiles

Digital presence

Phenomics Australia compliance and trust

Trust signal

Compliance1 record

Phenomics Australia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Phenomics Australia leadership team

Management profile

Number of profiles

Profiles7 records

Phenomics Australia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Phenomics Australia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phenomics Australia

What does Phenomics Australia do?

Phenomics Australia is a non-profit national research infrastructure provider offering specialized phenomics services across Australia through a network of 20+ service delivery centres. Its core offerings include biobanking of mouse sperm and embryos, in vivo and in vitro genome engineering and disease modelling, genotyping and phenotyping with integrated bioinformatics, functional genomics and high-throughput screening, and pathology services. These services are subsidized by Australian Government NCRIS funding and made openly accessible to academic, clinical, and industry researchers to advance precision medicine.

Is Phenomics Australia a public or private company?

Phenomics Australia is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Phenomics Australia founded?

Phenomics Australia was founded in 2007. It employs 11 to 50 people.

Where is Phenomics Australia based?

Phenomics Australia is headquartered in Canberra, Australia, in the Oceania region.

How does Phenomics Australia make money?

One revenue line is on record: research Infrastructure Services.

Who are Phenomics Australia's main competitors?

Broad incumbents on record are WuXi AppTec, Crown Bioscience, The Jackson Laboratory (JAX) and Charles River Laboratories. Emerging players are Newcells Biotech and Cyagen Biosciences. Inotiv is listed as an others. Direct peers are Taconic Biosciences, Bioplatforms Australia and Inventia Life Science.

Does Phenomics Australia have an API?

No public API is recorded for Phenomics Australia.

What industry is Phenomics Australia in?

Phenomics Australia's product category is Biomedical Research Infrastructure Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales